The role of Asprosin in patients with dilated cardiomyopathy

The role of Asprosin in patients with dilated cardiomyopathy

Abstract Background Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel...

Full description

Bibliographic Details
Main Authors: Ming-Shien Wen, Chao-Yung Wang, Jih-Kai Yeh, Chun-Chi Chen, Ming-Lung Tsai, Ming-Yun Ho, Kuo-Chun Hung, I-Chang Hsieh
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cardiovascular Disorders
Subjects:
Asprosin
Dilated cardiomyopathy
Heart failure
Hypoxia
Obesity
Online Access:http://link.springer.com/article/10.1186/s12872-020-01680-1

Internet

http://link.springer.com/article/10.1186/s12872-020-01680-1

Similar Items